| Product Code: ETC071560 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The China Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 196 Million in 2025 and is projected to reach USD 226 Million by 2032, growing at a CAGR of 2.1% from 2026 to 2032. This robust growth trajectory is primarily driven by a surge in infectious disease cases and an urgent demand for quick and accurate diagnostic solutions. The increasing government focus on enhancing healthcare infrastructure further supports this momentum, as does the rising public awareness regarding the importance of early detection and intervention.
This graph highlights how the China Infectious Disease Rapid Diagnostic Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -4.0% | Expansion of manufacturing activities |
| 2022 | 6.6% | Growing urbanization and commercial development |
| 2023 | -1.5% | Increasing smart city development projects |
| 2024 | 4.4% | Expansion of commercial construction activities |
| 2025 | 2.9% | Expansion of manufacturing activities |
| 2026 | 4.4% | Increasing industrial automation investments |
| 2027 | 2.6% | Increasing industrial automation investments |
| 2028 | 2.8% | Growing urbanization and commercial development |
| 2029 | 2.5% | Increasing industrial automation investments |
| 2030 | 2.5% | Expansion of manufacturing activities |
| 2031 | 2.5% | Growing renewable energy integration projects |
| 2032 | 3.2% | Growing urbanization and commercial development |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The demand for rapid diagnostic testing is gaining unprecedented attention in China, fueled by the ongoing fight against prevalent infectious diseases like COVID-19 and influenza. The Chinese population's increasing awareness of the value of prompt diagnostics is transforming patient management and treatment outcomes.
Supply chains are adapting to meet the escalating demand for point-of-care testing solutions, especially in rural and underserved areas. Manufacturers are responding by innovating rapidly, creating advanced testing kits that cater to the diverse needs of the healthcare system across the nation.
While the market is poised for growth, several factors could hinder its potential. Intense competition among manufacturers leads to price wars, impacting profitability and innovation. Additionally, the rapid pace of product development raises concerns over quality control, as not all tests meet stringent standards. Regulatory hurdles can also complicate the entry of new players and slow down the approval process for novel diagnostic solutions. Educating healthcare professionals and the public about the effective use of rapid tests remains a crucial challenge in fully leveraging the market's potential.
A notable trend within the China Infectious Disease Rapid Diagnostic Testing Market is the shift towards digital solutions. Technologies such as mobile applications for result interpretation and data management are gaining traction, enabling faster decision-making in clinical environments. Furthermore, there is an increased focus on improving the sensitivity and specificity of diagnostic tests, making them more reliable for clinical use. This evolution reflects the healthcare sector's commitment to integrating technology into testing processes, streamlining operations and enhancing patient care.
The market offers numerous investment opportunities, particularly in the development of innovative testing technologies that cater to the specific needs of the Chinese healthcare landscape. Expansion of distribution channels is crucial to ensure that diagnostic solutions reach a broader audience, particularly in remote areas where access has been historically limited. Collaborating with local healthcare entities and government agencies can also foster growth, presenting avenues for sustainable success amid changing market dynamics.
The Chinese government has introduced several policies aimed at regulating the Infectious Disease Rapid Diagnostic Testing Market, emphasizing quality and safety standards. Regulations require manufacturers to seek approval from the China Food and Drug Administration (CFDA), ensuring that products meet rigorous performance metrics before reaching the market. Ongoing public health initiatives highlight the importance of disease control, with significant investments directed towards enhancing diagnostic services, particularly in underserved areas. These measures are pivotal in expanding access to rapid testing solutions nationwide.
Looking ahead to the period between 2026 and 2032, the China Infectious Disease Rapid Diagnostic Testing Market is set to experience substantial growth. This forecast is underpinned by a sustained emphasis on early disease detection, increased prevalence of infectious diseases, and technological advancements that facilitate the rapid development of diagnostic kits. The ongoing impact of the COVID-19 pandemic continues to shape the market, further underscoring the necessity for efficient and effective rapid testing solutions.
Recent developments in the market reflect a growing inclination towards the integration of artificial intelligence in diagnostic testing processes. Several manufacturers have begun incorporating AI-driven algorithms to enhance the accuracy of test results and streamline the analysis process. Additionally, collaborative efforts are being established between technology firms and healthcare providers, aimed at pioneering next-generation testing solutions that can respond swiftly to emerging infectious disease threats.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Infectious Disease Rapid Diagnostic Testing Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022 & 2032F |
3.3 China Infectious Disease Rapid Diagnostic Testing Market - Industry Life Cycle |
3.4 China Infectious Disease Rapid Diagnostic Testing Market - Porter's Five Forces |
3.5 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.6 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 China Infectious Disease Rapid Diagnostic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in China |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in rapid diagnostic testing for infectious diseases |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for diagnostic tests in China |
4.3.2 Limited access to healthcare services in rural areas |
4.3.3 Competition from traditional laboratory testing methods |
5 China Infectious Disease Rapid Diagnostic Testing Market Trends |
6 China Infectious Disease Rapid Diagnostic Testing Market, By Types |
6.1 China Infectious Disease Rapid Diagnostic Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 China Infectious Disease Rapid Diagnostic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 China Infectious Disease Rapid Diagnostic Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 China Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Others, 2022-2032F |
7 China Infectious Disease Rapid Diagnostic Testing Market Import-Export Trade Statistics |
7.1 China Infectious Disease Rapid Diagnostic Testing Market Export to Major Countries |
7.2 China Infectious Disease Rapid Diagnostic Testing Market Imports from Major Countries |
8 China Infectious Disease Rapid Diagnostic Testing Market Key Performance Indicators |
8.1 Adoption rate of rapid diagnostic testing in healthcare facilities |
8.2 Average turnaround time for test results |
8.3 Rate of accuracy and reliability of rapid diagnostic tests |
8.4 Number of partnerships and collaborations in the market for technology advancement |
8.5 Level of government funding and support for infectious disease rapid diagnostic testing initiatives |
9 China Infectious Disease Rapid Diagnostic Testing Market - Opportunity Assessment |
9.1 China Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 China Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 China Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 China Infectious Disease Rapid Diagnostic Testing Market - Competitive Landscape |
10.1 China Infectious Disease Rapid Diagnostic Testing Market Revenue Share, By Companies, 2025 |
10.2 China Infectious Disease Rapid Diagnostic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here